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TITLE OF CASE Do not include “a case report” 
 
Induction of general anaesthesia by blowpipe darting in a fractious companion horse. 
 
SUMMARY Up to 150 words summarising the case presentation and outcome (this 
will be freely available online) 
 
A fractious nine-year-old, 520 kg, castrated Swiss Warmblood was presented with a history 
of anorexia, progressive weight loss and mild hind-limb lameness. Because of its 
temperament, standard physical examination was considered to be only feasible under 
general anaesthesia. For safety reasons, general anaesthesia was planned to be induced by 
blowpipe darting. Two attempts are described and discussed in the present report. The first 
attempt, using a combination of medetomidine and tiletamine-zolazepam, was unsuccessful. 
Conversely, detomidine combined with butorphanol, followed by a second dart of detomidine 
and tiletamine-zolazepam, proved to be adequate to induce anesthesia. Factors that could 
have influenced the outcome, such as different therapeutic approach, drug protocol and 
dosages, stress level or genetic mutations, are presented and discussed. 
 
 
BACKGROUND Why you think this case is important – why did you write it up? 
 
Induction of general anaesthesia by remote delivery is an uncommon practice in domestic 
horses. Nevertheless, this technique might represent the most suitable option for 
administering anaesthetic drugs in a safe and effective way to animals with a fractious 
temperament.  
Revised August 2017  Page 2 of 12 
Blowpipe darting, a simple and practical remote delivery method, allows precise dart 
injection when within a few meters of an animal by experienced personnel. The lower dart 
velocity when compared to compressed air projectors or gunpowder cartridge rifles, 
minimizes the risk of impact tissue trauma. [1] For these peculiarities, blowpipe darting can 
be seen as an adequate choice to deliver drugs avoiding animal handling in clinical settings.  
The ideal drug combination for remote immobilization must be effective and safe. It should 
also be concentrated enough that the volume does not exceed the dart capacity, non-irritant 
to allow intramuscular administration, provide rapid and smooth onset of action and be 
reversible. A number of different drugs and drug combinations have been described for 
chemical immobilization of non-domestic equids. Etorphine, a highly potent opioid, is one of 
the most commonly used drugs for this purpose;[2-3] succinylcholine, a depolarizing 
neuromuscular blocking agent, has been described for the immobilization of feral horses;[4] 
ketamine-medetomidine has been reported for Przewalski’s horses and “Judas 
donkeys”;[5,6] while tiletamine-zolazepam (TZ) for feral horses, Przewalski’s horses and 
zebras.[7–9]  
To our knowledge, no drug combinations and effective dosages have been reported for 
intramuscular induction of general anaesthesia in fractious companion horses so far. In the 
present report, two consecutive attempts to induce general anaesthesia through remote 
delivery of sedatives and anaesthetics in a fractious domestic horse are described. While the 
first attempt failed, the second was successful. Potential reasons for failure and success are 
presented and discussed. 
 
 
CASE PRESENTATION Presenting features, clinical and environmental history 
 
A nine year old, castrated male, Swiss Warmblood, and of estimated weight 520 kg, was 
presented to the Swiss Institute of Equine Medicine (ISME) with a history of anorexia, 
progressive weight loss and mild hind-limb lameness. The horse was known for its fractious 
temperament and had a history of highly aggressive reactions towards medical interventions 
and specifically towards injections. This has been noticed since the very early age but was 
exacerbated after surgical castration. Previously, the horse had been anaesthetized at the 
same hospital for sarcoid removal. On that occasion, a high level of danger was perceived by 
the personnel involved whenever contact with the horse was necessary. Even under deep 
sedation, the horse had still reacted violently to an intravenous injection, by targeted harsh 
kicking. A standard physical examination including oral examination, blood sampling and 
imaging was considered to be only feasible under general anaesthesia. To this end, induction 
of general anaesthesia by remote drug delivery followed by conventional anaesthetic 
maintenance was planned.   
 
On the morning of the planned procedure, the horse was transported to the hospital. Upon 
arrival, the horse was unloaded from the trailer and led by the owner directly into the 
anaesthetic induction box through the backdoor, which is accessible from the outside 
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pathway. The animal was left alone inside and free to move around. Care was taken to 
guarantee a quiet environment, with auditory contact to other horses. The horse showed a 
curious but calm attitude. A 3 ml gas pressurized dart (Mini-Ject 2000 Nylon syringe 
cylinder; Dist-inject) containing medetomidine (0.04 mg/kg) (Zalopine; 10 mg/ml, Orion 
Pharma, Espoo, Finland) and TZ (2 mg/kg) (Zoletil 100; Tiletamine 250 mg, Zolazepam 250 
mg, Virbac AG, Opfikon, Switzerland) was prepared. To reduce the total volume to be 
injected, medetomidine (2 ml) was used to dilute 1000 mg of TZ, resulting in a total volume 
below 3 ml. The dart, equipped with a woolen tailpiece and a smooth needle (1.5 x 35 mm) 
sealed with a silicon sleeve for impact protection, was fired by blowpipe (Mini-Inject 
Blowpipe 11mm; Dist-Inject) into the hindquarter musculature. The horse reacted 
immediately with a strong kick and became excited, showing attempts to escape and jump.  
Thirty-five minutes later, the horse showed signs of minimal sedation but was severely 
ataxic. While standing on a corner, he still reacted with aggressive behavior when 
approached and exhibited exaggerated behavioral reactions to external stimuli. Thus, a 
second dart containing TZ (1 mg/kg) and medetomidine (0.04 mg/kg) was shot. Twenty to 
thirty minutes later, the horse was mildly sedated but it still aroused in response to noise 
and remote tactile stimulation. Profuse sweating and increased urination were observed. At 
this time point approaching the horse for direct injections of further drugs was still deemed 
too dangerous. A third dart with additional medetomidine and TZ was considered unsafe and 
likely ineffective. Therefore, the decision was made to abandon the procedure and plan an 
alternative approach in the future. The horse recovered uneventfully and was sent home 7 
hours after the second dart. 
Nineteen days later, the horse was readmitted to the hospital. For this occasion, two 
consecutive darts were planned, the first one to sedate and the second one to induce general 
anaesthesia. A 5 ml dart (Mini-Ject 2000 Nylon syringe cylinder; Dist-inject) containing 
detomidine (0.05 mg/kg) (Equisedan; 10 mg/ml, Graeub AG, Bern, Switzerland) and 
butorphanol (0.03 mg/kg) (Morphasol; 10 mg/ml, Graeub AG, Bern, Switzerland) was 
prepared. Again, the dart was fired by blowpipe into the hindquarter muscles. Fifteen 
minutes later, clear sedative effects, including lowered head, wide stance and decreased 
responsiveness, became apparent. A second 5 ml dart containing TZ (4 mg/kg) and 
detomidine (0.02 mg/kg) was immediately fired. This dart did not empty completely. At 
visual inspection, it was estimated that half of the volume remained in the dart. Thus, a third 
dart with TZ (2 mg/kg) and detomidine (0.02 mg/kg) was shot. Within five minutes, severe 
ataxia with partial loss of posture was observed, followed by recumbency and 
unresponsiveness to stimulation. A 13-gauge catheter (Intranule; Vygon, Ecouen, France) 
was placed in the right jugular vein, and blood was withdrawn for complete hematology and 
chemistry profiles. The trachea was intubated with a 26 mm cuffed endotracheal tube. The 
horse was hoisted and positioned in dorsal recumbency. Because nystagmus was present, 
thiopental (0.5 mg/kg) (Thiopental Inresa; 50 mg/ml, Ospedalia AG, Hünenberg, 
Switzerland) was administered intravenously before moving into the operating room.  
Once in the operating room, the endotracheal tube was connected to a large animal circle 
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breathing system (Matrx VML Large Animal Anaesthesia System) equipped with a cycled 
ventilator (DHV 1000 Large Animal Ventilator, Surgivet, Smiths Medical). Anesthesia was 
maintained with Isoflurane (Attane; Provet AG, Lyssach, Switzerland) in oxygen and air 
mixture (50%-50%). Intermittent positive pressure ventilation was started once connected 
to the breathing circuit using a respiratory rate (RR) of 6 breaths/min, a tidal volume from 6 
L and a positive end-expiratory pressure of 5 cm H2O. After the first blood gas analysis tidal 
volume was reduced to 5 L. Heart rate and rhythm, invasive systolic, diastolic and mean 
arterial pressure (SAP, DAP, MAP), RR, SpO2, EtCO2 and EtIso were continuously monitored 
with a multi-parameter-anesthetic monitor (Datex Ohmeda S/5, GE) and recorded every 5 
minutes.  Fluid therapy was initiated with lactated Ringer’s solution at a rate of 
approximately 5 ml/kg/h and a urinary catheter connected to a collection bag was placed 
into the bladder. Once an adequate anaesthesia depth was achieved, the planned medical 
procedures were started. These included oral examination, dental floating, gastroscopy, 
carpal x-rays and vaccination. Penicillin (30000 IU/kg) (Penicillin Natrium; 10 Mio, Streuli 
Pharma SA, Uznach, Switzerland), gentamicin (6.5 mg/kg) (Pargenta; 50 mg/ml, Graueb 
AG, Bern, Switzerland) and flunixin meglumine (1.1 mg/kg) (Fluniximin; 50 mg/ml, Graueb 
AG, Bern, Switzerland) were administered intravenously. Due to the unique behavior 
displayed by the horse, an additional blood sample was taken for genomic sequencing. 
Arterial blood was sampled three times (25, 75 and 135 minutes after onset of recumbency) 
for blood gases and lactate analysis. At those time points, PaCO2 was 36.7, 44.1 and 51.6 
mm Hg respectively and PaO2 was 193, 142, 157 mm Hg respectively. Lactate levels ranged 
between 1.9 and 2.5 mmol/l. Heart rate oscillated around 30 bpm; EtIso fluctuated between 
0.83% and 1.0%. The lowest SpO2 value recorded was 85%, which was at the time of the 
first reading, and thereafter it stayed above 95%; EtCO2 values ranged between 31 and 44 
mm Hg; FiO2 was maintained between 51-61% throughout anesthesia. Seventy-five min 
after onset of recumbency, MAP decreased below 70 mm Hg. From this time point onwards, 
dobutamine (Dobutrex; 5 mg/ml, Teva Pharma AG, Basel, Switzerland) administered at a 
rate of 0.3 µg/kg/min, was sufficient to keep MAP above 70 mmHg until the completion of 
anesthesia. Total urine collected during anesthesia was 15 l. Bloodwork was unremarkable. 
Once the procedures were finished, isoflurane was discontinued. Total anaesthesia time, 
from onset of recumbency until discontinuation of isoflurane, was 165 min. The horse was 
disconnected from the breathing system, transferred to the recovery box, and positioned in 
left lateral recumbency. At this time point he had a rectal a temperature of 34.7°C and was 
wet; therefore the horse was dried by rubbing paper towels and covered with blankets. 
Mechanical ventilation with 100% oxygen was provided via a Hudson demand valve at a 
frequency of 6 breaths/min. Twenty minutes later, the frequency was reduced to 3 
breaths/min until the horse started to breath spontaneously. At this time point the 
endotracheal cuff was deflated and oxygen (10 l/minute) was insufflated through the 
endotracheal tube. Phenylephrine (Phenylephrine HCl 15%; Grosse Apotheke Dr. G. Bichsel 
AG, Interlaken, Switzerland) was administered intranasally at a volume of 10 ml in both 
nares. Seventy minutes after isoflurane discontinuation the horse had recovered the 
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swallowing reflex and was extubated. Romifidine (0.01 mg/kg) (Sedivet; 10 mg/ml, 
Boehringer Ingelheim, Basel, Switzerland) was administered IV and the jugular catheter was 
removed. The horse was then allowed to recover unassisted in the padded box. Muscle 
stiffness, shivering and limb rigidity were observed while the horse was recumbent. The 
horse stood up on the first attempt, 260 minutes after the end of anesthesia, moving directly 
from lateral recumbency to standing position. He was slightly ataxic but standing on all four 
limbs with minimal proprioceptive deficits. A recovery score of 2 (1: Excellent, 5: Very poor; 
adapted from Young and Taylor) was assigned. [10] 
 
 
INVESTIGATIONS If relevant 
 
Genomic sequencing was performed to investigate genetic factors that could have influenced 
drug response. 
 
 
DIFFERENTIAL DIAGNOSIS If relevant 
 
Stress, genetic mutations, altered pain state, drug resistance and behavioural problems, 
were suspected as potential alterations influencing the outcome. 
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TREATMENT If relevant  
 
 
 
 
 
OUTCOME AND FOLLOW-UP   
 
Three hours after standing the horse was sent home. 
 
 
DISCUSSION Include a very brief review of similar published cases  
 
Two attempts to induce general anaesthesia by blowpipe darting in a fractious domestic 
horse are described in the present report. In the first, two darts, one containing 
medetomidine (0.04 mg/kg) and TZ (2mg/kg) followed by a second one containing 
medetomidine (0.04 mg/kg) and TZ (1 mg/kg) failed to achieve recumbency 35 minutes 
apart. The second attempt resulted adequate to induce anaesthesia. It consisted in a two-
staged approach where sedation was achieved with the first dart using detomidine (0.05 
mg/kg) and butorphanol (0.03 mg/kg), followed by detomidine and TZ at an estimated dose 
of 0.03 mg/kg and 4 mg/kg respectively. This is the first description of successful IM general 
anaesthesia in a fractious companion horse. 
When planning general anaesthesia for this horse a number of issues were encountered. 
Safety of the horse as well as of the personal involved in the procedure must always be a 
priority on equine anaesthesia. To address safety in horses with aggressive reactions 
towards medical interventions a possibility is to undergo behavioral therapy and postpone 
the procedure until the animal is desensitized. It has been reported an efficient rehabilitation 
in equine cases with positive-reinforcement based habituation. [11] However, due to relative 
urgency of the procedure and the extreme fractious temperament of the horse, it was 
considered not feasible within a reasonable time frame in this case. Therefore, because the 
main concern was minimizing risks, darting was considered to be the best drug delivery 
method. Darts can be projected via blowpipe, compressed air projector, or gunpowder 
cartridge rifle.[1] Among available delivery systems, blowpipe was selected because of being 
an accurate method for short distances, being silent and producing a limited und thus safer 
projectile velocity.[1] Darting injuries have been attributed to misuse of the drug-delivery 
system and inexperience of personnel.[12] The anesthetist was trained and familiar with the 
delivery method optimizing the effectiveness of drug administration as well as safety for the 
horse and personnel. The darts used were gas-pressurized, constructed of lightweight 
plastic. This dart type was selected as it has a lower risk of causing injuries than the rapid-
injection darts,[13] which expel their content by powder charge. However, as seen in the 
second attempt of the present case, it might happen that the pressurized gas is not enough 
to expel the whole dart content because of insufficient charge or depressurization before or 
during the flight. This is a common problem causing incomplete discharge, which is difficult 
to notice before darting. 
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The main issue confronted in the current case was the impossibility to induce anaesthesia at 
the first attempt. As a result of the failed attempt, an alternative approach was devised with 
modifications to the drug protocol and dosages for the following attempt. A two-stage 
sequence of darts was planned: the first to sedate the horse, containing detomidine (0.05 
mg/kg) and butorphanol (0.03 mg/kg); and the second one to induce anaesthesia, 
containing TZ at a higher dose than the one used on the first attempt (4 mg/kg) combined 
with detomidine (0.02 mg/kg). It was planned to administer the second dart only in case of 
evident sedation following the first dart, mimicking the approach used in routine equine 
clinical anaesthesia. Due to incomplete discharge of the second dart, containing TZ and a 
second dose of detomidine, a third dart was delivered to reach the planned dosages. On this 
occasion the time interval between the two darts was short, so that the onset of anaesthetic 
action can most probably be attributed to the sum of both. 
Whether the success of the second attempt can be credited to the increased drug dosages, 
the reduced dosing interval, the modifications to the drug protocol, or to the two-stage 
approach remains unclear. However, those factors are the most likely to have influenced the 
successful attempt. While detomidine-butorphanol combinations are commonly used for 
equine premedication and have highly predictable effects, high doses of medetomidine 
combined with tiletamine-zolazepam had not been described in fractious companion horses 
before. On the other side, reports of successful anaesthetic induction using combinations of a 
dissociative agent with an α2-agonist in non-domestic equids, as well as in a variety of wild 
animals justify the choice of drugs used in the first attempt.[14–18]  
Another key issue was the selection of drugs to be used for darting. Although a number of 
different drug combinations have been reported for chemical immobilization of non-domestic 
equids, no specific information about intramuscular anaesthetic induction in fractious 
companion horses was found in the literature.  
Etorphine, a potential effective choice according to previous reports,[2-3] was discarded 
because of its limited access. Etorphine is in the Yellow list of the International Narcotics 
Control Board listed in the Schedule I in accordance with the Single Convention on Narcotic 
Drugs, 1961.[19] Currently, there are not authorized products containing etorphine in 
Switzerland, and although it is possible to import it with Swissmedic’s approval,[20] the 
process of getting the required licenses may take several weeks. Furthermore, etorphine 
presents risk of fatal complications for humans manipulating it because of its high potency.  
Similarly, succinylcholine was excluded for a number of reasons. It leads to immobilization 
as an abrupt collapse of support muscles, which could cause severe injuries, and it produces 
tachyarrhythmia and hypertension in horses.[4] Moreover, succinylcholine does not provide 
anaesthesia or analgesia making its use ethically unacceptable.  
The use of ketamine (2.1 mg/kg) in combination with medetomidine (0.09 mg/kg) has been 
reported to be successful to immobilize Przewalski’s horses using a CO2 injection rifle.[5] 
This drug combination also worked appropriately to immobilize “Judas donkeys” with dose 
rates of 0.14 mg/kg medetomidine and 4.1 mg/kg ketamine.[6] However, the characteristics 
of the present case, being a 520 kg horse, to be darted by blowpipe, and the concentration 
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of the ketamine available (100 mg/ml), made this combination unpractical because of the 
high volume needed, which would have been a minimum of 15 ml.   
As an alternative to ketamine, tiletamine has been widely used for the immobilization of wild 
animals. Tiletamine is a dissociative anesthetic that is commercialized combined with 
zolazepam, a benzodiazepine derivative, in equal mixture. TZ has been reported in feral 
horses in combination with xylazine and butorphanol,[7] and in zebras and Przewalski’s 
horses in combination with romifidine with successful results.[8] One benefit of TZ is that it 
is available as a powder; therefore, it can be reconstituted in high concentrations minimizing 
the final volume to be injected. The disadvantages are the longer onset, longer duration of 
action, and impossibility to antagonize it.[21]  
Among α2-agonists, medetomidine was chosen because of the availability of a highly 
concentrated solution (Zalopine 10 mg/ml). This, used to solve TZ, resulted in a total 
injection volume suitable for a 3-ml dart. The dose rate of medetomidine (0.04 mg/kg) 
chosen for the first dart might be equipotent to 4 mg/kg of xylazine.[22] Xylazine doses 
ranging from 2.6 to 4.1 mg/kg, combined with TZ and butorphanol, have been reported to 
be adequate to anaesthetize feral horses.[7] Unfortunately, only slight sedation and strong 
ataxia were observed in the present case after the first dart, but also when the same drugs 
were administered again 30 minutes later at the same doses. Since increasing the dose of 
α2-agonists has been shown to prolong the duration of action without enhancing the 
potency,[23] a ceiling effect might have been responsible for the lack of sedative efficacy of 
the second dart. While comparing equisedative doses of xylazine and medetomidine, it is 
described that medetomidine elicits stronger and longer ataxia than xylazine.[22] This might 
help to explain the severe ataxia observed in the present case. It is also possible that the 
dose of TZ used (3 mg/kg) was insufficient, as it is in the lower range of doses reported as 
effective in non-domestic equids, which are 3.2, 3.5 and 5.0 mg/kg in feral horses,[7] 3.3 
mg/kg in Przewalski’s horses and 1.8 mg/kg in Hartmann mountain zebras.[8] Furthermore, 
the 30-minute delay between the first and the second dart could have been too long, since it 
has been recommended to redose within 20 minutes if the first dose of drugs is not 
effective.[7]  
Avoiding stress and fear for the animal before and during the anaesthetic induction 
procedure was identified as a key factor to enhance the probability of success. Stress and 
excitation, accompanied by a high catecholamine levels, are known to impair the efficacy of 
alpha-2 agonists. Indeed, in race horses after strenuous exercise, doses required to induce 
sedation and anaesthesia are much higher than in horses at rest.[24,25] Thus, efforts were 
made to avoid handling by unknown people, to minimize the time spent in the hospital 
environment and to maintain an overall quiet atmosphere. However, at the first attempt 
excitation and fear were clearly recognizable after the first dart was shot, and from that 
moment on throughout the entire process. This stress level might have influenced the 
unsuccessful outcome. Despite following a very similar approach for the second attempt, a 
lower level of excitation was noticed and a good level of sedation was reached soon after the 
first dart. This could have been because of adaptation to the repeated situation. It has been 
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described that the transport-induced stress response in horses, indicated by cortisol release 
and changes in heart rate, decreases with repeated transport.[26] 
The exaggerated behavioral responses of this horse to routine medical interventions, and the 
resistance showed to the anaesthetic drugs on the first attempt were found to be 
exceptional. Therefore, a genomic sequencing was performed. The potential for genetic 
factors to influence drug response should be considered when observing variations from the 
normal effects.[27] When sequencing the genome of this horse, no protein-changing 
variants were detected within the three genes that encode for separate subtypes of α2 
adrenoreceptors, ADRA2A, ADRA2B and ADRA2C.[28] However, heterozygous intronic 
private variants were found in the pain-associated genes SCN11A and TRPA1. The SCN11A 
gene encodes a member of the sodium channel family, and is highly expressed in nociceptive 
neurons of dorsal root ganglia and trigeminal ganglia.[29] Variants in this gene have been 
described to influence pain thresholds regulated by inflammatory mediators in mice.[30] TRP 
channels appear to be involved in the transduction of several nociceptive stimuli.[29] 
Variants in the TRPA1 gene have been associated with increased pain sensitivity in 
humans.[31] Therefore, it is possible that the horse was suffering from an altered sensitivity 
to painful stimuli, which might have accounted for its unique behavior. However, these 
variants were located in introns of the respective genes, which reduce the possibility of 
having a functional effect. On the other hand, other private variants were found to be more 
prone to have a functional effect. The CACNA1G gene, a calcium voltage-gated channel, 
which is involved in synaptic transmission, and the C15orf59 gene, involved in postsynaptic 
inhibition, which may have an influence on the nociceptive pathway. 
In conclusion, this case presented a challenge because of the importance of assuring safety, 
the scarce information about intramuscular anaesthetic induction in companion horses, the 
limitations on drug selection, and the drug resistance encountered on the first attempt. In 
addition, it also proved that general anaesthesia in a fractious companion horse can be 
achieved by blowpipe darting, and it may suggest that separating sedation and induction in 
two sequential darts could be beneficial. Furthermore, we highly recommend to plan 
diligently the approach and to make effort for minimizing horse stress and anxiety. 
 
 
LEARNING POINTS/TAKE HOME MESSAGES 3 to 5 bullet points – this is a required 
field 
 
• Safety of the personnel and of the horse must always be a priority in equine 
anaesthesia. 
• General anaesthesia in a fractious companion horse can be achieved by blowpipe 
darting. 
• Diligent planning of the approach is required and special effort should be made to 
minimize stress and anxiety in fractious horses. 
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